HomeHealth TopicsWomenPrimary Ovarian Insufficiency
Back to Women
Primary Ovarian Insufficiency
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Women

Primary Ovarian Insufficiency

Primary ovarian insufficiency (POI) occurs when the ovaries stop functioning normally before age 40, leading to hormonal changes and potential fertility challenges.

Overview

Primary ovarian insufficiency (POI) is a condition where the ovaries stop working normally before the age of 40. While fertility naturally declines around age 40 or later, POI causes these changes to occur much earlier, sometimes even during the teenage years.

POI is distinct from premature menopause. In premature menopause, periods stop before age 40 and pregnancy is no longer possible. With POI, some women may still experience occasional periods and may even become pregnant.

Causes & Risk Factors

In approximately 90% of cases, the exact cause of POI is unknown. Research indicates it is related to problems with follicles—the small sacs in the ovaries where eggs mature. Potential causes or contributors include:

  • Genetic disorders, such as Fragile X syndrome and Turner syndrome
  • Autoimmune diseases, including thyroiditis and Addison disease
  • Chemotherapy or radiation therapy
  • Metabolic disorders
  • Exposure to toxic substances like cigarette smoke, chemicals, and pesticides

Risk factors include a family history of POI, certain genetic conditions, autoimmune diseases, viral infections, cancer treatments, and age (becoming more common between 35 and 40).

Symptoms

The primary sign is usually irregular or missed periods. Later symptoms resemble those of natural menopause:

  • Hot flashes and night sweats
  • Irritability and poor concentration
  • Decreased sex drive and pain during sex
  • Vaginal dryness

Associated Health Conditions

Lower hormone levels associated with POI increase the risk for:

  • Anxiety and depression
  • Dry eye syndrome and eye surface disease
  • Heart disease, including increased risk of atherosclerosis
  • Infertility
  • Low thyroid function (hypothyroidism)
  • Osteoporosis, a bone disease causing weak, brittle bones

Diagnosis

Diagnosis may involve a medical history, pregnancy test, physical exam, blood tests for hormones and chromosomes, and a pelvic ultrasound to check for enlarged ovaries or follicles.

Treatment & Management

While there is no proven treatment to restore normal ovarian function, symptoms and risks can be managed through:

  • Hormone therapy for menopause (HRT) to replace estrogen and other hormones.
  • Calcium and vitamin D supplements to support bone health.
  • In vitro fertilization (IVF) for those wishing to become pregnant.
  • Lifestyle modifications, including regular physical activity and maintaining a healthy weight.
  • Targeted treatments for associated conditions like hypothyroidism.

Frequently Asked Questions

Yes, unlike premature menopause, POI does not mean the complete cessation of ovarian function. Approximately 5% to 10% of women with POI will experience spontaneous ovulation and can conceive naturally. However, fertility is unpredictable and often diminished. If natural conception does not occur within six months of diagnosis, clinicians typically recommend discussing assisted reproductive technologies, such as in vitro fertilization (IVF) with donor eggs, as a more reliable option for building a family.
If you have a family history of POI or early menopause, ask your provider about Fragile X premutation testing, which is the most common genetic cause of POI. Additionally, because autoimmune conditions are a leading cause, testing for anti-ovarian antibodies, thyroid antibodies (such as TPO), and adrenal antibodies (for Addison disease) is recommended. A karyotype analysis may also be ordered to rule out chromosomal abnormalities like Turner syndrome mosaicism.
Yes, the lack of estrogen before the age of 40 significantly increases the risk of atherosclerosis and cardiovascular events compared to women who undergo natural menopause later. To manage this, it is critical to maintain optimal blood pressure, cholesterol levels, and blood sugar. Regular cardiovascular screening, including lipid panels and blood pressure monitoring, should begin at diagnosis. Lifestyle modifications such as regular aerobic exercise, a heart-healthy diet, and smoking cessation are essential components of long-term risk reduction.
Women with POI are generally advised to continue hormone replacement therapy until the average age of natural menopause, which is around 51 years, rather than stopping at 40. This extended duration is crucial to protect bone density and cardiovascular health. The dosing is also different; POI patients often require higher doses of estrogen and progestin to mimic the physiological levels of a premenopausal woman, whereas standard menopause HRT uses lower doses to manage symptoms.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab